Intracellular calcium stores and oscillatory contractions in arteries from genetically hypertensive rats

Hypertension Research - Clinical and Experimental

Volumn 19, Issue 2, 1996, Pages 103-111

  Tostes, Rita C A ^a,d   Storm, Deborah S ^b   Chi, David H ^c   Webb, R Clinton ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Intracellular Ca2+ stores; Oscillatory contractions; Spontaneously hypertensive rats; Tetraethylammonium chloride; Vascular smooth muscle

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIMYCIN; CALCIUM ION; CYCLOPIAZONIC ACID; NORADRENALIN; PHOSPHOLIPASE C INHIBITOR; RYANODINE; TETRYLAMMONIUM; THAPSIGARGIN;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; MALE; NONHUMAN; RAT; SARCOPLASMIC RETICULUM; SPONTANEOUSLY HYPERTENSIVE RAT; TAIL ARTERY; VASCULAR SMOOTH MUSCLE;

EID: 0030036940     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.19.103     Document Type: Article

References (41)

1. Lamb FS, Myers H, Hamlin MH, Webb RC: Oscillatory contractions in tail arteries from genetically hypertensive rats. Hypertension 1985; 7 (Suppl 1): 125-130.
2. Lamb FS, Webb RC: Regenerative electrical activity and arterial contraction in hypertensive rats. Hypertension 1989; 13: 70-76.
3. Myers JH, Lamb FS, Webb RC: Norepinephrine-induced phasic contractile activity in tail arteries from genetically hypertensive rats. Am J Physiol 1985; 284: H419-H423.
4. Webb RC, Schreur KD, Papadopoulos SM: Oscillatory contractions in vertebral arteries from hypertensive subjects. Clin Physiol 1992; 12: 69-77.
5. Hollenberg NK, Sandor T: Vasomotion of renal blood flow in essential hypertension; oscillations in xenon transition. Hypertension 1984; 6: 579-585.
6. Watts SW, Traub O, Webb RC: Effects of Ramipril on contractile oscillations in arteries from genetically hypertensive rats. Clin Exp Hypertens 1994; 16 (6): 881-898.
7. Iwaki M, Nakaya Y, Kawano K, Mizobuchi S, Nakaya S, Mori H: Tetraethylammonium-induced contraction of rabbit coronary artery. Heart Vessels 1988; 4: 141-148.
8. Lambert CR, Pepine CJ: Tetraethylammonium-induced phasic arterial constriction: temporal and spatial characteristics. Am J Physiol 1986; 251: H436-H442.
9. Droogmans G, Raeymaaekers L, Casteels SR: Electro and pharmacomechanical coupling in the smooth muscle cells of the rabbit ear artery. J Gen Physiol 1977; 70: 129-148.
10. Harder DR, Sperelakis N: Action potentials induced in guinea pig arterial smooth muscle by tetraethylammonium. Am J Physiol 1979; 237: C75-C80.
11. Chen Q, Cannell M, van Breemen C: The superficial buffer barrier in vascular smooth muscle. Can J Physiol Pharmacol 1992; 70: 509-514.
12. Iino M: Calcium-induced calcium release mechanism in guinea pig taenia caeci. J Gen Physiol 1989; 94: 363-383.
13. Amedee T, Benham CD, Bolton TB, Byrne NG, Large WA: Potassium, chloride and nonselective cation conductances opened by noradrenaline in rabbit ear artery cells. J Physiol Lond 1990; 423; 551-568.
14. 2+ influx. Nature 1993; 364: 809-814.
15. + current by means of a phosphatase and a diffusible messenger. Nature 1993; 364: 814-818.
16. 2+ entry. Cell Calcium 1986; 7: 1-12.
17. Shima H, Blaustein M: Modulation of evoked contractions in rat arteries by ryanodine, thapsigargin, and cyclopiazonic acid. Circ Res 1992; 70: 968-977.
18. lino M, Kobayshi T, Endo M: Use of ryanodine for functional removal of the calcium store in smooth muscle cells of the guinea pig. Biochem Biophys Res Commun 1988; 152: 417-422.
19. Hisayama T, Takayangi I: Ryanodine: its possible mechanism of action in the caffeine sensitive calcium store of smooth muscle. Pflugers Arch 1988; 412: 376-381.
20. 2+-ATPase. Proc Natl Acad Sci 1990; 87: 2466-2470.
21. 2+- ATPase of sarcoplasmic reticulum. J Biol Chem 1989; 264: 17816-17823.
22. Turla MB, Webb RC: Augmented phosphoinositide metabolism in aortas from genetically hypertensive rats. Am J Physiol 1990; 258: H173-H178.
23. Bruner CA, Myers JH, Sing CF, Jokelainen PT, Webb RC: Genetic association of hypertension and vascular changes in stroke-prone spontaneously hypertensive rats. Hypertension 1986; 8: 904-910.
24. Colantuoni A, Bertuglia S, Intaglietta M: Quantitation of rhythmic diameter changes in arterial micro-circulation. Am J Physiol 1984; 246: H508-H517.
25. Funk W, Endrich B, Messmer K, Intaglietta M: Spontaneous arteriolar vasomotion as a determinant of peripheral vascular resistance. Int J Microcirc Clin Exp 1983; 2: 11-25.
26. Meininger GA, Lubrano VM, Granger HJ: Hemodynamic and microvascular responses in the hindquarters during the development of renal hypertension in rats: evidence for the involvement of an autoregulatory component. Circ Res 1984; 55: 609-622.
27. Ely JA, Ambroz C, Baukal AJ, Christensen SB, Balla T, Catt KJ: Relationship between agonist- and thapsigargin-sensitive calcium pools in adrenal glomerulosa cells. J Biol Chem 1991; 266: 18635-18641.
28. 2+ uptake is not decreased in aorta from DOCA hypertensive rats: functional assessment with cyclopiazonic acid. Can J Physiol Pharmacol 1995 (in press)
29. Berridge MJ: Inositol triphosphate and diacylglycerol as second messengers. Biochem J 1984; 220: 345-360.
30. Hauesler G, Thorens S: Effects of tetraethylammonium on contractile, membrane and cable properties of rabbit artery muscle. J Physiol 1980; 303: 203-224.
31. Holman ME, Suprenant A: Effects of tetraethylammonium chloride on sympathetic neuromuscular transmission in saphenous artery of young rabbits. J Physiol Lond 1980; 305: 451-465.
32. Kanagy NL, Ansari MN, Ghosh S, Webb RC: Recycling and buffering of intracellular calcium in vascular smooth muscle from genetically hypertensive rats. J Hypertens 1994; 12: 1365-1372.
33. Kwan CY: Dysfunction of calcium handling by smooth muscle in hypertension. Can J Physiol Pharmacol 1985; 63: 366-374.
34. Dominiczak AF, Webb RC, Bohr DF: Calcium and the malfunction of the plasma membrane in hypertension. J Vasc Med Biol 1991; 3: 178-180.
35. Kannan MS, Daniel EE: Formation of gap junctions by treatment in vitro with potassium conductance blockers. J Cell Biology 1978; 78: 338-348.
36. Gabella G: Structural apparatus for force transmission in smooth muscle. Physiol Rev 1962; 42: 213-227.
37. Miller SM, Garfield RE, Daniel EE: Improved propagation in myometrium associated with gap junctions during parturition. Am J Physiol 1989; 256: C130-C141.
38. Watts SW, Tsai, ML, Loch-Caruso R, Webb RC: Gap junctional communication and vascular smooth muscle reactivity: use of tetraethylammonium chloride. J Vasc Res 1994; 31: 307-313.
39. Cole WC, Garfield RE: Evidence for physiological regulation of gap junction permeability. Am J Physiol 1986; 251: C411-C420.
40. 2+. Am J Physiol 1987; 253: C607-C612.
41. 2+ in vascular smooth muscle. J Hypertens 1994; 12 (Suppl 10): S133-S143.